1413.7000 -15.20 (-1.06%)
NSE Jun 06, 2025 15:31 PM
Volume: 113.7K
 

1413.70
-1.06%
Prabhudas Lilladhar
RAINBOW's Q4FY25 consolidated EBITDA grew by 9% YoY (down 15% QoQ) to Rs1.15bn, but 5% below our estimates due to weaker occupancy. RAINBOW enjoys higher margins, strong FCF generation with net cash B/S, and healthy...
Number of FII/FPI investors increased from 228 to 236 in Mar 2025 qtr.
More from Rainbow Childrens Medicare Ltd.
Recommended